Literature DB >> 12972307

Neck node metastasis after successful brachytherapy for early stage tongue carcinoma.

Tsuneaki Nakagawa1, Hitoshi Shibuya, Ryoichi Yoshimura, Masahiko Miura, Norihiko Okada, Seiji Kishimoto, Mitsuo Amagasa, Ken Omura.   

Abstract

BACKGROUND AND
PURPOSE: The accuracy of factors for predicting lymph node metastasis in patients with early-stage (stage I and II) mobile tongue carcinoma and prognostic factors associated with the clinical and pathological findings of lymph node metastasis were examined.
MATERIAL AND METHODS: Between 1971 and 1998, 616 patients with early stage mobile tongue carcinoma were treated by brachytherapy with or without external irradiation. Neck lymph node metastasis occurred in a total of 237 cases, and 191 of them were not associated with primary failure. Neck dissection was performed in 169 of these 191 cases, and 16 cases were treated by radiotherapy. A pathological analysis was possible in 159 of the 169 neck dissection cases.
RESULTS: There were 88 tongue cancer recurrences, and the incidence of neck metastasis was 38% (191/528) in the cases of primary controlled early tongue carcinoma, and 25% (38/151) and 41% (153/377), in stage-I and -II carcinoma, respectively. Neck metastasis was diagnosed within 12 months in 80% of cases, and within 24 months in 95%. Macroscopic appearance, tumor thickness and tumor length were identified as significant risk factors by a univariate analysis, but macroscopic appearance was the only significant risk factor identified by a multivariate analysis (P<0.001). The incidence of cervical lymph node metastasis was 62% among the invasive/ulcerative type tongue carcinomas, and was lower among the superficial type and exophytic/nodular type (20 and 35%, respectively). Regional and/or distant failure occurred in 75 of the 169 neck dissection cases (44%). The incidence of regional/distant failure was extremely high (49/68=72%) in the extra-nodal invasion group, and extra-nodal invasion was found even in small metastatic node less than 1 cm in length (20%).
CONCLUSIONS: The macroscopic appearance of the primary tongue carcinoma has a major impact on the incidence of lymph node metastasis in patients with early tongue cancer, and extra-nodal invasion was the dominant risk factor for regional and distant failure. Treatment policy for clinically negative neck metastasis in early tongue cancer patients should be determined after considering the possibility of neck metastases and the morbidity associated with elective neck dissection.

Entities:  

Mesh:

Year:  2003        PMID: 12972307     DOI: 10.1016/s0167-8140(03)00187-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

1.  Brachytherapy for tongue cancer in the very elderly is an alternative to external beam radiation.

Authors:  R Khalilur; K Hayashi; H Shibuya
Journal:  Br J Radiol       Date:  2010-08-03       Impact factor: 3.039

2.  Roles of IGFBP-3 in cell migration and growth in an endophytic tongue squamous cell carcinoma cell line.

Authors:  Esther Feng Ying Ng; Atsushi Kaida; Hitomi Nojima; Masahiko Miura
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

3.  Prognostic implication of NOTCH1 in early stage oral squamous cell cancer with occult metastases.

Authors:  Shan Wang; Haixia Fan; Jiankai Xu; Eryang Zhao
Journal:  Clin Oral Investig       Date:  2017-09-02       Impact factor: 3.573

4.  Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer.

Authors:  Rina Fujisawa; Hitoshi Shibuya; Naoki Harata; Keiko Yuasa-Nakagawa; Kazuma Toda; Keiji Hayashi
Journal:  Int J Clin Oncol       Date:  2013-02-02       Impact factor: 3.402

Review 5.  Current status and perspectives of brachytherapy for head and neck cancer.

Authors:  Hitoshi Shibuya
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

6.  Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer.

Authors:  Lubos Tuček; Jiri Petera; Igor Sirák; Milan Vošmik; Helena Doležalová; Simona Brokešová; Miroslav Hodek; Linda Kašaová; Petr Paluska
Journal:  Rep Pract Oncol Radiother       Date:  2011-08-06

7.  Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL.

Authors:  Sayako Oota; Hitoshi Shibuya; Ryo-ichi Yoshimura; Hiroshi Watanabe; Masahiko Miura
Journal:  Radiat Oncol       Date:  2006-07-12       Impact factor: 3.481

8.  PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma.

Authors:  A Eslami; K Miyaguchi; K Mogushi; H Watanabe; N Okada; H Shibuya; H Mizushima; M Miura; H Tanaka
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

9.  High-dose-rate interstitial brachytherapy in early stage oral tongue cancer - 15 year experience from a tertiary care institute.

Authors:  Anshuma Bansal; Sushmita Ghoshal; Arun S Oinam; Suresh Chander Sharma; Bhaswanth Dhanireddy; Rakesh Kapoor
Journal:  J Contemp Brachytherapy       Date:  2016-02-29

10.  198Au grain implantation for early tongue cancer in patients of advanced age or poor performance status.

Authors:  Yoshiharu Ryu; Hitoshi Shibuya; Keiji Hayashi
Journal:  J Radiat Res       Date:  2013-05-17       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.